Three New Members Join The Wistar Institute Board of Trustees

Three New Members Join The Wistar Institute Board of Trustees

April 21, 2008

(PHILADELPHIA—April 22, 2008) – The Wistar Institute recently welcomed three new members to its board of trustees; Dani Paul Bolognesi, Ph.D., George J. Vergis, Ph.D., and Dan W. Matthias.

Bolognesi is the CEO and chairman of B3Bio Inc., a new biotech venture in the field of RNA therapeutics. Bolognesi participated in the discovery in the mid-1980s of AZT, considered the first effective AIDS drug, and co-founded the biopharmaceutical company Trimeris, which also has focused on the development of anti-viral drugs. 

Bolognesi is the James B. Duke Professor emeritus in the Department of Surgery at Duke University Medical Center. He also served formerly as deputy director and chief operating officer of the Duke Comprehensive Cancer Center, director of Duke’s Center for AIDS Research, and director of the NIH Central Laboratory for HIV Vaccine Clinical Trials. He earned his doctorate from Duke University.

Vergis is president and CEO of Neose Technologies Inc., a clinical-stage biopharmaceutical company in Horsham that focuses on the development of therapeutic proteins. He is the former vice president of new product development and commercialization of BASF/Knoll Pharmaceutical Company and associate director of medical and scientific affairs for the Warner-Lambert/Parke-Davis division of Pfizer.

Vergis also worked previously as a clinical research scientist for American Home Products: Wyeth-Ayerst Laboratories. He earned his doctorate in physiology from the Pennsylvania State University.

Matthias is the chairman, CEO, and co-founder of Mothers Work Inc., a company that manufactures and sells maternity apparel through 1,600 stores in the United States and Canada. He also served as manager of ZaBeCor Pharmaceutical Company, LLC, a start-up company involved in the development of a drug for the control of asthma.

Matthias served as a founding director of Zilog, Inc., an early microcomputer company, and as founder and president of Qyx, where he developed and marketed the first editing electronic typewriter. He founded and directed an early welfare-to-work initiative and has served for several years as a member of the executive committee of the board of the Eastern Pennsylvania Region of the Anti-Defamation League. He earned bachelor’s master’s degrees in electrical engineering from the Georgia Institute of Technology and received an MBA from Harvard Business School. 

The Wistar Institute is an international leader in biomedical research with special expertise in cancer research and vaccine development. Founded in 1892 as the first independent nonprofit biomedical research institute in the country, Wistar has long held the prestigious Cancer Center designation from the National Cancer Institute. The Institute works actively to transfer its inventions to the commercial sector to ensure that research advances move from the laboratory to the clinic as quickly as possible. The Wistar Institute: Today’s Discoveries – Tomorrow’s Cures. On the web at www.wistar.org.

                                                ###